Press Releases
04/18/02
CEREGENE EXPANDS INTO NEW FACILITY
SAN DIEGO, Calif., April 18, 2002—Ceregene, Inc., a biotechnology company focused on gene therapies for neurological disorders such as Alzheimer's disease and Parkinson's disease, announced today that it has moved into a newly constructed facility with approximately 20,000 square feet of laboratory and administrative space.
Located in the University Towne Centre area of San Diego, Ceregene’s new facility is in close proximity to the University of California, San Diego, The Salk Institute for Biological Studies and many of San Diego’s leading biotechnology companies and research institutions.
"Ceregene’s new facility provides us with the latest in laboratory capabilities and room to grow as we accelerate our research and development programs,"stated Jeffrey M. Ostrove, Ph.D., president and chief operating officer of Ceregene.
Ceregene’s new address is: 9381 Judicial Drive, Suite 130, San Diego, CA 92121-3831.
Ceregene, Inc. is a San Diego-based biotechnology company focused on the development and commercialization of gene therapies for neurological disorders including Alzheimer’s disease and Parkinson’s disease. Ceregene was launched in January 2001 and is a majority-owned subsidiary of Cell Genesys, Inc. (Nasdaq: CEGE), which is headquartered in Foster City, CA.